The global randomization and trial supply management market was valued at USD 791.6 million in 2025 and is projected to reach USD 2,083.8 million by 2033, expanding at a CAGR of 13.0% from 2026 to 2033. Market growth is primarily driven by the rising complexity of clinical trials, particularly in oncology, rare diseases, and advanced therapeutic areas, where precise patient randomization and efficient supply coordination are critical for study success.

Modern clinical trials are increasingly adopting adaptive designs, multi-arm studies, and global multi-site execution models, significantly increasing operational challenges. RTSM platforms address these complexities by enabling real-time automation of patient randomization and investigational drug supply management. For instance, innovations such as IQVIA’s advanced IRT solutions for early-phase trials introduced in 2025 demonstrate how flexible configurations and real-time cohort adjustments are enhancing the ability to manage complex and evolving study protocols.

Additionally, the rapid rise of decentralized and hybrid clinical trials (DCTs) is further accelerating demand for RTSM solutions. As clinical research shifts toward remote patient participation, direct-to-patient drug distribution, and virtual monitoring, there is a growing need for systems that can manage distributed inventories across multiple geographies. RTSM platforms play a crucial role in enabling these patient-centric trial models by ensuring seamless coordination, improving operational efficiency, and enhancing trial accessibility on a global scale.

Download a free sample copy of the Randomization and Trial Supply Management Market report to gain access to detailed insights, market coverage, and study inclusions.

Key Market Trends & Insights

• North America dominated the market with a 51.0% revenue share in 2025, driven by strong clinical research infrastructure, high adoption of advanced trial technologies, and the presence of major pharmaceutical and CRO players.
• Europe is projected to register the fastest CAGR of 14.7% from 2026 to 2033, supported by increasing clinical trial activities, regulatory support for innovation, and growing adoption of decentralized trial models.
• By delivery mode, the cloud and web-based segment led the market with a 91.4% revenue share in 2025, owing to its scalability, real-time access capabilities, and ease of integration across global trial networks.
• By end use, contract research organizations (CROs) accounted for the largest market share of 37.3% in 2025 due to their extensive involvement in managing complex, multi-site clinical trials for pharmaceutical and biotech companies.

Key Randomization and Trial Supply Management Company Insights

Leading companies in the RTSM market include IQVIA, Oracle, Veeva Systems Inc., and Medidata (Dassault Systèmes). These players are focusing on strengthening their platforms through cloud expansion, AI integration, interoperability enhancements, and strategic collaborations to improve end-to-end clinical trial management.

• IQVIA offers integrated RTSM/IRT solutions within its broader clinical research ecosystem, supporting highly complex global trials through advanced data analytics and operational automation.
• Oracle provides cloud-based RTSM solutions designed for scalability, interoperability, and seamless integration across clinical trial workflows.
• Veeva Systems Inc. delivers cloud-enabled RTSM platforms that enhance collaboration, data consistency, and operational efficiency across clinical development processes.
• Medidata (Dassault Systèmes) offers RTSM capabilities through its Rave Clinical Cloud, enabling advanced randomization, supply optimization, and streamlined trial execution.

Key Randomization & Trial Supply Management Companies

• IQVIA
• Oracle
• Medidata (Acquired by Dassault Systèmes)
• Veeva Systems Inc.
• Parexel
• Suvoda LLC
• 4G Clinical
• Signant Health
• Calyx
• Almac Group
• Clinion
• Mednet
• ICON plc

Explore Grand View Horizon to see global and regional level statistics related to the Randomization and Trial Supply Management Market

Grand View Research offers

• Focused market intelligence reports on specific geographies or high-growth segments.
• Extended forecast timelines for long-term planning.
• Competitor Benchmarking and Supply Chain Analysis
• Inclusion of regulatory and policy assessments.
• Inclusion of custom data models, KPIs, or applications unique to your business
• Specific high-impact Data Decks and Tables to support effective decision making
• And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering